Neurocrine Biosciences Presents CAHtalog Registry Analysis at ENDO 2025

Neurocrine Biosciences announced results from a new analysis of the CAHtalog registry, showing that most patients with classic congenital adrenal hype...
Home/KnloSights/Clinical Trial Updates/Neurocrine Biosciences Presents CAHtalog Registry Analysis at ENDO 2025